Tuis002773 • SHE
add
Chengdu Kanghong Pharma Grp Co Ltd
Vorige sluiting
¥29,75
Dagwisseling
¥29,55 - ¥30,34
Jaarwisseling
¥16,62 - ¥30,48
Markkapitalisasie
27,36 mjd CNY
Gemiddelde volume
12,14 m
P/V-verhouding
22,36
Dividend-opbrengs
-
Primêre beurs
SHE
Marknuus
Business Insider
45 minute gelede
'This Is Maybe the Most Dangerous Market of My Career': Top Investor
0,67%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 1,20 mjd | 9,70% |
Bedryfskoste | 622,89 m | 13,69% |
Netto inkomste | 400,02 m | 7,09% |
Netto winsgrens | 33,37 | -2,37% |
Wins per aandeel | — | — |
EBITDA | 507,93 m | 4,67% |
Effektiewe belastingkoers | 14,30% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 6,08 mjd | 20,00% |
Totale bates | 9,67 mjd | 9,50% |
Totale aanspreeklikheid | 627,52 m | -3,45% |
Totale ekwiteit | 9,05 mjd | — |
Uitstaande aandele | 919,87 m | — |
Prys om te bespreek | 3,02 | — |
Opbrengs op bates | 11,85% | — |
Opbrengs op kapitaal | 12,73% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 400,02 m | 7,09% |
Kontant van bedrywe | 433,08 m | 6,69% |
Kontant van beleggings | -2,69 mjd | -34,16% |
Kontant van finansiering | -1,21 m | -1 025,44% |
Netto kontantverandering | -2,26 mjd | -41,20% |
Beskikbare kontantvloei | 143,20 m | 11,91% |
Meer oor
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.
As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Gestig
03 Okt. 1996
Webwerf
Werknemers
4 462
